Tel Aviv, Israel / Vancouver, Canada, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” oregon the "company"), a biotech institution focused connected find and improvement of caller psychedelic-derived therapeutics to lick large under-treated wellness problems, is pleased to denote that each of the matters enactment guardant earlier shareholders for information and support astatine its gathering held connected December 28, 2022 (the "Meeting"), arsenic acceptable retired successful the Company's Management Information Circular dated November 28, 2022, were approved by the requisite bulk of votes formed astatine the Meeting, including the support of the Company’s rolling banal enactment program and an summation to the magnitude of options disposable for issuance thereunder, and an summation to the magnitude of restricted stock units, and underlying communal shares, disposable for issuance pursuant to the Company’s Restricted Share Unit Plan.
About Clearmind Medicine Inc.
Clearmind is simply a psychedelic pharmaceutical biotech institution focused connected the find and improvement of caller psychedelic-derived therapeutics to lick wide and underserved wellness problems, including intoxicant usage disorder. Its superior nonsubjective is to probe and make psychedelic-based compounds and effort to commercialize them arsenic regulated medicines, foods oregon supplements.
The company’s intelligence portfolio presently consists of 7 patent families. The institution intends to question further patents for its compounds whenever warranted and volition stay opportunistic regarding the acquisition of further intelligence spot to physique its portfolio.
Shares of Clearmind are listed for trading connected Nasdaq and the Canadian Securities Exchange nether the awesome "CMND" and the Frankfurt Stock Exchange nether the awesome “CWY”.
For further accusation visit: https://www.clearmindmedicine.com or contact:
Investor Relations
invest@clearmindmedicine.com
Telephone: (604) 260-1566
General Inquiries
Info@Clearmindmedicine.com
www.Clearmindmedicine.com
English (US)